Literature DB >> 334460

Ovulation inhibition by a new low-dose progestagen.

L Viinikka, E Hirvonen, O Ylikorkala, S Nummi, P Virkkunen, T Ranta, U Alapiessa, R Vihko.   

Abstract

Keywords:  Adrenal Cortex Hormones--analysis; Biology; Clinical Research; Contraception; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--administraction and dosage; Contraceptive Agents--side effects; Diseases; Endocrine System; Enzymes And Enzyme Inhibitors; Enzymes--analysis; Estradiol--analysis; Estrogens; Evaluation; Family Planning; Follicle Stimulating Hormone--analysis; Gonadotropins; Gonadotropins, Pituitary; Hematological Effects; Hemic System; Hepatic Effects; Hormones; Human Volunteers; Luteinizing Hormone--analysis; Menstruation Disorders; Oral Contraceptives; Physiology; Progestational Hormones; Progesterone--analysis; Progestins, Low-dose--administraction and dosage; Progestins, Low-dose--side effects; Research Methodology

Mesh:

Substances:

Year:  1977        PMID: 334460     DOI: 10.1016/0010-7824(77)90129-9

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


× No keyword cloud information.
  1 in total

1.  Metabolism of a new synthetic progestagen, Org 2969, in female volunteers. Pharmacokinetics after an oral dose.

Authors:  L Viinikka; O Ylikorkala; R Vihko; H P Wijnand; M Booij; F van der Veen
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.